gary taubes glp 1 (@garytaubes) / Posts / X Rethinking Diabetes by Gary Taubes:
Description
Rybelsus is the world's first oral GLP-1 receptor agonist
In a statement published on 6 June 2025, the PRAC said it had reviewed all available data on []
The findings do not prove that GLP-1 receptor agonist drugs treat psychiatric conditions, and randomized clinical trials are still needed.

Methylcobalamin B12 (525mcg, 21,875% DV) the bioactive form, not cyanocobalamin

Taking Your First Ozempic Shot

The global burden of chronic disorders such as Parkinsons disease (PD) has rapidly increased over recent decades